Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports

by Lars Jørgensen, Peter C. Gøtzsche, Tom Jefferson
Published 2020-02-01

Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publicatio...

by Lars Jørgensen, Peter C. Gøtzsche, Tom Jefferson
Published 2020-02-01

Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic revi...

by Lars Jørgensen, Peter C. Gøtzsche, Tom Jefferson
Published 2018-01-01

Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer.

by Oddmund Nordgård, Gurpartap Singh, Steinar Solberg, Lars Jørgensen, Ann Rita Halvorsen, Rune Smaaland, Odd Terje Brustugun, Åslaug Helland
Published 2013-01-01

Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors

by Maria Moksnes Bjaanæs, Gro Nilsen, Ann Rita Halvorsen, Hege G. Russnes, Steinar Solberg, Lars Jørgensen, Odd Terje Brustugun, Ole Christian Lingjærde, Åslaug Helland
Published 2021-10-01

Mammalian diaphanous-related formin 1 regulates GSK3β-dependent microtubule dynamics required for T cell migratory polarization.

by Baoxia Dong, Steven S Zhang, Wen Gao, Haichun Su, Jun Chen, Fuzi Jin, Ajay Bhargava, Xiequn Chen, Lars Jorgensen, Arthur S Alberts, Jinyi Zhang, Katherine A Siminovitch
Published 2013-01-01

Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients

by Ann Rita Halvorsen, Ann Rita Halvorsen, Mads Haugland Haugen, Åsa Kristina Öjlert, Marius Lund-Iversen, Lars Jørgensen, Steinar Solberg, Gunhild M. Mælandsmo, Gunhild M. Mælandsmo, Odd Terje Brustugun, Odd Terje Brustugun, Åslaug Helland, Åslaug Helland, Åslaug Helland
Published 2020-11-01

Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs

by Christopher G. Parker, Christian A. Kuttruff, Andrea Galmozzi, Lars Jørgensen, Chien-Hung Yeh, Daniel J. Hermanson, Yujia Wang, Marta Artola, Steven J. McKerrall, Christopher M. Josyln, Bjarne Nørremark, Georg Dünstl, Jakob Felding, Enrique Saez, Phil S. Baran, Benjamin F. Cravatt
Published 2017-12-01